Are you looking for a stock?

Try one of these

Related Videos

Angiotech Pharmaceuticals to file for Chapter 11

Angiotech Pharmaceuticals Inc. (ANP-T) said it will file for bankruptcy protection under Canada's Companies' Creditors Arrangement Act to implement a recapitalization deal that will cut $250 million US of its debt.

All of the company's existing shareholders will be wiped out without any compensation under the proposed deal. The transaction is supported by noteholders representing more than 84 percent of the outstanding subordinated notes.

Angiotech has also lined up a $25 million debtor-in-possession (DIP) loan from Wells Fargo Capital Finance LLC to continue operations while under creditor protection.

Under the proposed plan, noteholders will exchange their subordinated notes for a share in 96 percent of the reorganized company's common stock. CTV Two CTV News CTV News Channel BNN - Business News Network CP24